XNAS 12 Mar, 2026 2:09 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Robert Lenz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Kaya Kamlesh Pai Panandiker | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 195,000 | 195,000 | - | - | Employee Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 1,255 | 1,255 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 896 | 0 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 3,944 | 3,944 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 3,944 | 0 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 17,929 | 0 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 22,449 | 22,449 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 53,787 | 53,787 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 53,787 | 0 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 17,929 | 17,929 | - | - | Stock Option (Right to Buy) | |
| Anna Eramo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 155,812 | 155,812 | - | - | Employee Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 1,255 | 0 | - | - | Stock Option (Right to Buy) | |
| Zachary Prensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 896 | 896 | - | - | Stock Option (Right to Buy) | |
| Rebecca Luse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 22,449 | 22,449 | - | - | Stock Option (Right to Buy) | |
| Richard Anthony Silva | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 80,899 | 80,899 | - | - | Employee Stock Option (Right to Buy) | |
| Richard Anthony Silva | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 8,964 | 8,964 | - | - | Employee Stock Option (Right to Buy) | |
| Richard Anthony Silva | SVP, Technical Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 8,964 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anna Eramo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 6,275 | 6,275 | - | - | Employee Stock Option (Right to Buy) | |
| Anna Eramo | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 6,275 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anna Eramo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 26,893 | 26,893 | - | - | Employee Stock Option (Right to Buy) | |
| Anna Eramo | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 26,893 | 0 | - | - | Employee Stock Option (Right to Buy) |